IPO market

Unlisted Ideas

Invest in Pre-IPO shares

IPO Ideas

Invest in IPO in just 3 clicks

About Us

Molbio Diagnostics IPO subscription

BBMainboardBSE, NSEListed

Listed at

980

+21.44%

Molbio Diagnostics IPO is a Mainboard IPO. Issue size is ₹940 Cr. Price band is ₹768 to ₹807 per share. Minimum investment is ₹14,526. Lot size is 18 shares. Open from 10 Aug 2026 to 12 Aug 2026. on 13 Aug 2026. Listing on 17 Aug 2026 at BSE, NSE. Managed by Kotak Mahindra Capital Co.Ltd., IIFL Capital Services Ltd., Jefferies India Pvt.Ltd., and Motilal Oswal Investment Advisors Ltd. Registrar: Kfin Technologies Limited. Key details for GMP, subscription, price, , and listing in one place.

Live IPO subscription for Molbio Diagnostics IPO across categories. Total demand ₹57.32 Cr vs offered ₹81.59 L.

Official documents:DRHP.

Follow the latest IPO & unlisted research on iOS and Android.

Google Play App Store

Molbio Diagnostics IPO subscription

BBMainboardBSE, NSEListed

Listed at

980

+21.44%

Live IPO subscription for Molbio Diagnostics IPO across categories. Total demand ₹57.32 Cr vs offered ₹81.59 L.

Official documents:DRHP.

Subscription Status

Category	Offered	Placed	Times
QII	23,25,146	43,33,82,148	186.39
NII	17,43,859	8,68,40,604	49.80
NII (>10L)	11,62,573	5,90,76,594	50.82
NII (<10L)	5,81,286	2,77,64,010	47.76
Retail	40,69,004	5,27,19,318	12.96
Employee	20,520	2,72,466	13.28
Total	81,58,529	57,32,14,536	70.26

Application Wise Subscription

Category	Offered	Placed	Times
HNI (>10L)	4,613	46,462	10.07
HNI (3-10L)	2,306	106,649	46.25
Retail	226,055	2,557,840	11.32
Employee	-	8,917	-
Total	232,974	2,719,868	11.67

Molbio Diagnostics IPO subscription FAQs

How to read QIB / NII / Retail demand and what it implies.

What is the Molbio Diagnostics IPO subscription status?

The Molbio Diagnostics IPO subscription status shows how many times the issue has been subscribed across different investor categories such as QIB, NII (HNI), and Retail. It reflects the demand for the IPO during the subscription period.

Where can I check live Molbio Diagnostics IPO subscription numbers?

You can check live Molbio Diagnostics IPO subscription data on this page, which is updated based on official data released during the IPO subscription period.

What are the investor categories in Molbio Diagnostics IPO subscription?

The Molbio Diagnostics IPO subscription is divided into the following categories: Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII / HNI), and Retail Individual Investors (RII). Each category has a separate quota and subscription data.

What does QIB subscription mean in Molbio Diagnostics IPO?

QIB subscription in Molbio Diagnostics IPO indicates the demand from institutional investors such as mutual funds, banks, and insurance companies.

What does NII or HNI subscription mean in Molbio Diagnostics IPO?

NII (also known as HNI) subscription in Molbio Diagnostics IPO represents bids from high-net-worth investors who apply for shares above the retail limit.

What does Retail subscription mean in Molbio Diagnostics IPO?

Retail subscription in Molbio Diagnostics IPO shows demand from individual investors who apply within the retail investment limit specified in the IPO details.

How often is Molbio Diagnostics IPO subscription data updated?

Molbio Diagnostics IPO subscription data is updated multiple times during market hours based on information published by stock exchanges.

Does higher Molbio Diagnostics IPO subscription guarantee allotment?

No, higher Molbio Diagnostics IPO subscription does not guarantee . In case of oversubscription, is done through a lottery system as per SEBI guidelines.

Is Molbio Diagnostics IPO subscription data official?

Yes, the subscription data shown for Molbio Diagnostics IPO is based on official data released by stock exchanges, but it may change during the day.

How does Molbio Diagnostics IPO subscription impact listing?

IPO subscription indicates demand, but the actual listing performance depends on market conditions, company fundamentals, and investor sentiment at the time of listing.